Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications.

Lisa Kouladjian O'Donnell Danijela GnjidicTimothy F ChenSarah N Hilmer

Published in: Therapeutic advances in drug safety (2019)

Name: Feasibility study of the Drug Burden Index with Home Medicines Review.Website: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368523Trial ID: ACTRN 12615000539538.

Keyphrases

risk assessment
phase iii
study protocol
healthcare
phase ii
clinical trial
risk factors
drug induced
heavy metals
open label
adverse drug
emergency department
sensitive detection
reduced graphene oxide
meta analyses